Cargando…
TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) exhibits high recurrence and metastasis rates. Although target therapy has significantly improved the prognosis of some patients with ccRCC, the median survival rate remains poor. Thus, there remains a need for the identification of novel potential targets for...
Autores principales: | Wu, Ping, Xiang, Tingting, Wang, Jing, Lv, Run, Wu, Guangzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714062/ https://www.ncbi.nlm.nih.gov/pubmed/33015999 http://dx.doi.org/10.1002/2211-5463.12993 |
Ejemplares similares
-
Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis
por: Wu, Ping, et al.
Publicado: (2021) -
Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study
por: Lv, Xian-Qiang, et al.
Publicado: (2022) -
Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021) -
MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment
por: Guo, Lingyu, et al.
Publicado: (2023) -
A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)